Skip to main content
logo
Immatics N.V. (IMTX)
NASDAQ: IMTX · Real-Time Price · USD
7.31
-0.23 (-3.05%)
At close: Oct 23, 2026, 4:00 PM EDT
7.08
-0.23 (-3.15%)
Pre-market: Oct 26, 2026, 6:53 AM EDT

Immatics Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
41.748.27155.8454172.8334.76
Revenue Growth
-67.95%-69.03%188.60%-68.76%397.17%11.23%
Gross Profit
-176.71-135.577.76-64.6766.05-52.81
Operating Income
-226.78-182.02-38.62-101.7329.95-86.29
Net Income
-206.55-196.4515.22-94.6527.7-93.34
Earnings Per Share
-1.60-1.610.14-1.180.40-1.48
EPS Growth
------

Revenue by Segment
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Moderna, United States
32.9637.2562.795.37--
Bristol-Myers Squibb (BMS), United States
8.7411.0278.150.7126.113.14
Genmab, Denmark
--14.95-2.079.626.93
Revenue (Total)
41.748.27155.8454172.8334.76

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
393.35469.34604.45425.9362.21145.12
Total Debt
14.6115.6416.215.414.569.85
Net Cash (Debt)
378.74453.7588.25410.49347.64135.26
Net Cash Growth
-17.85%-22.87%43.30%18.08%157.01%-40.09%
Net Cash Per Share
2.933.715.515.105.052.15

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-205.87-176.63-158.0318.23100.13-84.75
Capital Expenditures
-3.69-6.56-16.27-30.8-5.74-5.11
Free Cash Flow
-209.56-183.18-174.3-12.5794.39-89.85
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
--280.87%4.98%-119.76%38.22%-151.92%
Operating Margin
-543.79%-377.11%-24.78%-188.39%17.33%-248.23%
Pretax Margin
-495.79%-411.13%13.70%-179.63%24.32%-268.49%
Profit Margin
-495.27%-407.01%9.77%-175.29%16.03%-268.49%
FCF Margin
-502.49%-379.53%-111.85%-23.28%54.62%-258.47%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--53.86-22.43-
Forward PE
-223.37223.37223.37223.37-
P/FCF Ratio
----6.58-
PS Ratio
20.9724.845.2614.943.6021.39